A drug with the SMILES Cn1c(=O)c2c(nc(N/N=C/c3c(O)n(C4CCCCC4)c(=S)[nH]c3=O)n2C)n(C)c1=O has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of 12.568%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cn1c(=O)c2c(nc(N/N=C/c3c(O)n(C4CCCCC4)c(=S)[nH]c3=O)n2C)n(C)c1=O
Cn1c(=O)c2c(nc(N/N=C/c3c(O)n(C4CCCCC4)c(=S)[nH]c3=O)n2C)n(C)c1=O
8-[(2E)-2-[(1-cyclohexyl-6-hydroxy-4-oxo-2-sulfanylidenepyrimidin-5-yl)methylidene]hydrazinyl]-1,3,7-trimethylpurine-2,6-dione